Annual Accounts Payable
$11.04 M
+$10.06 M+1032.31%
31 December 2023
Summary:
NKGen Biotech Common Stock annual accounts payable is currently $11.04 million, with the most recent change of +$10.06 million (+1032.31%) on 31 December 2023. NKGN annual accounts payable is now at all-time high.NKGN Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$12.69 M
-$141.00 K-1.10%
30 June 2024
Summary:
NKGen Biotech Common Stock quarterly accounts payable is currently $12.69 million, with the most recent change of -$141.00 thousand (-1.10%) on 30 June 2024. Over the past year, it has increased by +$4.76 million (+59.91%). NKGN quarterly accounts payable is now -1.10% below its all-time high of $12.84 million, reached on 31 March 2024.NKGN Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NKGN Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1032.3% | +59.9% |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
NKGN Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +1032.3% | -1.1% | +1202.0% |
| 5 y | 5 years | at high | +1032.3% | -1.1% | +1202.0% |
| alltime | all time | at high | +1032.3% | -1.1% | +1202.0% |
NKGen Biotech Common Stock Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $12.69 M(-1.1%) |
| Mar 2024 | - | $12.84 M(+16.3%) |
| Dec 2023 | $11.04 M | $11.04 M(+39.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | $7.94 M(+122.1%) |
| June 2023 | - | $3.57 M(+266.6%) |
| Dec 2022 | $975.00 K(-43.1%) | $975.00 K |
| Dec 2021 | $1.71 M | - |
FAQ
- What is NKGen Biotech Common Stock annual accounts payable?
- What is the all time high annual accounts payable for NKGen Biotech Common Stock?
- What is NKGen Biotech Common Stock annual accounts payable year-on-year change?
- What is NKGen Biotech Common Stock quarterly accounts payable?
- What is the all time high quarterly accounts payable for NKGen Biotech Common Stock?
- What is NKGen Biotech Common Stock quarterly accounts payable year-on-year change?
What is NKGen Biotech Common Stock annual accounts payable?
The current annual accounts payable of NKGN is $11.04 M
What is the all time high annual accounts payable for NKGen Biotech Common Stock?
NKGen Biotech Common Stock all-time high annual accounts payable is $11.04 M
What is NKGen Biotech Common Stock annual accounts payable year-on-year change?
Over the past year, NKGN annual accounts payable has changed by +$10.06 M (+1032.31%)
What is NKGen Biotech Common Stock quarterly accounts payable?
The current quarterly accounts payable of NKGN is $12.69 M
What is the all time high quarterly accounts payable for NKGen Biotech Common Stock?
NKGen Biotech Common Stock all-time high quarterly accounts payable is $12.84 M
What is NKGen Biotech Common Stock quarterly accounts payable year-on-year change?
Over the past year, NKGN quarterly accounts payable has changed by +$4.76 M (+59.91%)